Abcam is a startup based in the United Kingdom, most recent round Series-c-plus.
Abcam is a startup based in the United Kingdom. Its most recent tracked round is Series-c-plus.
Abcam is a supplier of protein research tools to life scientists and is publicly listed on the London Stock Exchange following an IPO.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.